TCR2 THERAPEUTICS INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
TCR2 THERAPEUTICS INC. has filed 318 SEC EDGAR filings since 07 Sep 2018

SEC filing history

Showing 276-300 of 318 matching filings.

Per page
25
Current page
12
4

FORM 4 SUBMISSION

Filing date
21 Feb 2019
Reporting date
19 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Feb 2019
Reporting date
19 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Feb 2019
Reporting date
19 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90936

SCHEDULE 13G

Filing date
21 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Feb 2019
Reporting date
19 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-229066

424(B)(4)

Filing date
15 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-229691

S-8

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 333-229066

CT ORDER filing

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-229066

EFFECT filing

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
13 Feb 2019
Reporting date
13 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Feb 2019
Reporting date
13 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Feb 2019
Reporting date
13 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Feb 2019
Reporting date
13 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Feb 2019
Reporting date
13 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Feb 2019
Reporting date
13 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Feb 2019
Reporting date
13 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Feb 2019
Reporting date
13 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Feb 2019
Reporting date
13 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Feb 2019
Reporting date
13 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Feb 2019
Reporting date
13 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Feb 2019
Reporting date
13 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Feb 2019
Reporting date
13 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Feb 2019
Reporting date
13 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Feb 2019
Reporting date
13 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-229066

FWP

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .